✦ LIBER ✦

TCT-8 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent: Prospective, Randomized, Multicenter Trial

✍ Scribed by Lee, Byoung Kwon; Bum-Kee, Hong; Yoon, Young Won; Min, Pil-Ki; Kwon, Hyuck Moon; Kim, Byoung Keuk; Hong, Myeong-Ki; Jang, Yang soo

Book ID: 122156542
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 158 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.735

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-140 Prospective Multicenter Registry

TCT-140 Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study.

✍ De la Torre Hernandez, Jose M.; Oteo Dominguez, Juan F.; Hernandez, Felipe; Abdu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Six-Month Versus 12-Month Dual Antiplate

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

✍ Gwon, H.-C.; Hahn, J.-Y.; Park, K. W.; Song, Y. B.; Chae, I.-H.; Lim, D.-S.; Han 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 983 KB

TCT-488 Risk of stent thrombosis with 6

TCT-488 Risk of stent thrombosis with 6 vs. 12 months dual antiplatelet therapy after new generations drug-eluting stents implantation: final results of the multicenter prospective ESTROFA-DAPT study

✍ De la Torre Hernandez, Jose M.; Oteo Dominguez, Juan F.; Hernandez, Felipe; Cama 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Rationale and design of a randomized, do

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

✍ Robert A. Byrne; Stefanie Schulz; Julinda Mehilli; Raisuke Iijima; Steffen Massb 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Efficacy and safety of 12 versus 48 mont

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial

✍ Gérard Helft, Claude Le Feuvre, Jean Louis Georges, Didier Carrie… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 213 KB

Rationale and design of the dual antipla

Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions

✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB